Nucleic Acid Testing Market - Trends, Outlook, and
Opportunity Analysis, 2018-2026
Nucleic acid testing (NAT) or nucleic acid amplification test (NAAT) is one of the advanced
diagnostic test increasingly gaining traction over conventional culture methods, owing to high
efficiency and accuracy. Furthermore, nucleic acid testing has potential application in various
life threating diseases including cancer, infectious disease, genetic and mitochondrial disorders,
and also in development of personalized and precision medicine. NAT is an efficient diagnostic
method, which significantly reduces the procedural time and consumption of reagents.
Moreover, nucleic acid testing is increasingly being used for screening blood donation samples
to reduce the risk of transfusion transmitted infections (TTIs), thus aiding in growth of the
nucleic acid testing market.
Request PDF Brochure Of Research Report:
https://www.coherentmarketinsights.com/insight/request-pdf/1644
Nucleic Acid Testing Market – Driver
Nucleic acid tests are extensively used for screening and diagnosis of various infectious diseases.
Moreover, growing prevalence of infectious diseases and management of epidemics of new
diseases has led to increasing demand for advanced diagnostic tests such as nucleic acid testing.
For instance, according to the World Health Organization (WHO), in 2015, around 32,000
estimated deaths from tuberculosis and around 3, 23,000 new cases of TB were registered in
the European region. Furthermore, according to the Centers for Disease Control and Prevention
(CDC), around 5,251 deaths due to influenza infection were registered in 2015, in the U.S.
According to the National Ambulatory Medical Care Survey: 2015 data findings, 16.8 million
visits to physician offices for infectious and parasitic diseases were registered in the U.S.
Nucleic acid testing (NAT) enables to examine various changes in gene sequence and copy
number, and provides information regarding disease recurrence and possible condition of patient
to likely respond to a particular treatment. Moreover, NAT can identify, which patient have
undergone inherited mutations, which eventually helps to identify whether the patient is at
increased risk of developing cancer or not. Increasing incidence of cancer in various
geographical areas is a major driving factor for growing adoption of nucleic acid testing. For